Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at ...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) ordinary shares between July ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and ...

ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI news and ratings too important to miss. Artificial intelligence is rapidly ...